Business, energy, technology, markets and global industry news from Business News Today

Brigham and Women’s Hospital

PharmaDeviceNews Brigham and Women's Hospital
Representative image of multiple sclerosis research as Tiziana Life Sciences’ nasal foralumab reduces brain inflammation markers in a positive Phase 2a trial.
Pharma & Biotech

Nasal foralumab reduces brain inflammation marker in Phase 2a multiple sclerosis trial

Tiziana Life Sciences' nasal foralumab meets Phase 2a multiple sclerosis endpoints. Explore brain inflammation, fatigue and safety findings.

Read More
Editorial infographic showing Bayer’s amyloidosis PET tracer results, with cardiac imaging, a PET scanner and laboratory visuals, highlighting 94% sensitivity in Phase III and new HFSA analyses on earlier diagnosis and finerenone treatment gaps.
Medical Devices & Diagnostics

Bayer’s experimental PET scan detected 94% of cardiac amyloidosis cases. Can it identify the disease earlier?

Bayer's amyloidosis PET tracer showed 94% sensitivity in Phase III. New HFSA analyses examine earlier diagnosis and finerenone treatment gaps.

Read More
Medical Devices & Diagnostics

Why 10x Genomics is betting on peripheral blood to decode complex immune disorders

Find out how 10x Genomics and Brigham & Women's Hospital are using single-cell profiling to redefine autoimmune diagnostics. Can it change patient care?

Read More